hellotayssir/FinQA_TAT-QA_financial_finetuning_dataset huggingface dataset:
NOTE 17. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT
FINANCIAL INSTRUMENTS
Financial instruments include:
The carrying amounts of cash and cash equivalents, accounts receivable and accounts payable equal their fair values because of the short-term nature of these instruments.
Table:
 | December 31, | 
 | 2018 | 2019
Financial assets: |  | 
Cash and cash equivalents | 285,907 | 497,874
Accounts receivable | 173,450 | 199,535
Financial liabilities: |  | 
Accounts payable | 80,640 | 119,712


Question: What is the Accounts receivable for 2018?
Answer: 173,450
Investing Cash Flow Activities
Year Ended December 31, 2019 Compared with the Year Ended December 31, 2018
Net cash used in investing activities – continuing operations during the year ended December 31, 2019 resulted from the absence of the sale of businesses compared to prior year. The sale of Netsmart and OneContent produced significant investing cash inflows during 2018, which was partially offset with cash paid for the acquisitions of Practice Fusion and Health Grid. Capital expenditures also decreased in 2019 compared with prior year.
Year Ended December 31, 2018 Compared with the Year Ended December 31, 2017
We had cash inflows from investing activities – continuing operations during the year ended December 31, 2018 compared with cash outflows from investing activities – continuing operations during the year ended December 31, 2017, which was primarily driven by cash proceeds of $567 million from the sale of our investment in Netsmart and $241 million of net cash proceeds from the divestiture of the OneContent business during 2018.
Cash used in investing activities also included the purchase of Practice Fusion and Health Grid, which were mostly offset by lower overall capital expenditures during 2018.
Net cash used in investing activities – discontinued operations increased during the year ended December 31, 2018 compared with the prior year, primarily due to larger business acquisitions completed by Netsmart during 2018.
Table:
 |  | Year Ended December 31, |  |  | 
(In thousands) | 2019 | 2018 | 2017 | 2019 $ Change from 2018 | 2018 $ Change from 2017
Capital expenditures | $(16,600) | $(31,309) | $(38,759) | $14,709 | $7,450
Capitalized software | (113,836) | (113,308) | (118,241) | (528) | 4,933
Cash paid for business acquisitions, net of cash acquired | (23,443) | (177,233) | (169,823) | 153,790 | (7,410)
Cash received from sale of businesses, net | 0 | 807,764 | 0 | (807,764) | 807,764
Purchases of equity securities, other investments and related intangible assets, net | (7,191) | (16,934) | (5,606) | 9,743 | (11,328)
Other proceeds from investing activities | 14 | 54 | 215 | (40) | (161)
Net cash (used in) provided by investing activities - continuing operations | (161,056) | 469,034 | (332,214) | (630,090) | 801,248
Net cash used in investing activities - discontinued operations | 0 | (221,021) | (80,758) | 221,021 | (140,263)
Net cash (used in) provided by investing activities | $(161,056) | $248,013 | $(412,972) | $(409,069) | $660,985


Question: What is the average Capitalized software, for the year 2019 to 2018?
Answer: -113572
Calculation: -(113,836+113,308) / 2
(g) Prepaid Expenses and Other Current Assets:
A summary of prepaid expenses and other current assets is as follows (in millions):
Prepaid inventory represents inventory in-transit that has been paid for but not received.
Table:
 | September 2019 | September 2018
Prepaid expenses | $1.8 | $1.6
Prepaid inventory | 5.3 | 3.3
 | $7.1 | $4.9


Question: What is the value of the company's 2018 prepaid inventory as a percentage of its total prepaid expenses and other current assets?
Answer: 67.35
Calculation: 3.3/4.9
35 Related party transactions
Key management1 compensation
1 Key management comprises the directors of intu properties plc and the Executive Committee who have been designated as persons discharging managerial responsibility (PDMR).
During 2017 the Group’s joint ventures in intu Puerto Venecia and intu Asturias sold shares in subsidiaries, previously wholly owned by the respective joint ventures, listed on the Spanish MaB to PDMRs of the Group. The total value of the shares at 31 December 2019 is €1.0 million for each joint venture, representing 1 per cent of the respective outstanding share capital. The sale of shares in these entities was required to comply with Spanish MaB free float listing requirements. The Group provided an interest-free loan to PDMRs to enable them to purchase the shares. The loans are treated as a taxable benefit which accordingly is included in the above table. In line with the terms of the relevant loan agreements entered into, the loans are repayable in full upon cessation of employment or the sale of the underlying assets. Further to the exchange of contracts in respect of the sale of intu Puerto Venecia in December 2019 and of intu Asturias in January 2020, the relevant PDMRs sold these shareholdings in January 2020 and February 2020 respectively. All outstanding loans in respect of the above arrangements have been repaid to the Company in full or in part. For those loans which have been partially repaid, the outstanding balance has been written off by the Company.
Table:
Key management1 compensation |  | 
£m | 2019 | 2018
Salaries and short-term employee benefits | 4.7 | 4.9
Pensions and other post-employment benefits | 0.3 | 0.8
Share-based payments | 1.5 | 1.7
 | 6.5 | 7.4


Question: What is the percentage change in the Pensions and other post-employment benefits from 2018 to 2019?
Answer: -62.5
Calculation: (0.3-0.8)/0.8
3. Operating (loss)/profit
Detailed below are the key amounts recognised in arriving at our operating (loss)/profit
Notes: 1 The year ended 31 March 2019 included €nil (2018: €80 million credit, 2017: €127 million charge) reported in other income and expense in the consolidated income statement
2 Reported in other income and expense in the consolidated income statement.
Table:
 | 2019 | 2018 | 2017
 | €m | €m | €m
Net foreign exchange losses/(gains)1 | 1 | (65) | 133
Depreciation of property, plant and equipment (note 11): |  |  | 
Owned assets | 5,795 | 5,963 | 6,253
Leased assets | 59 | 47 | 12
Amortisation of intangible assets (note 10) | 3,941 | 4,399 | 4,821
Impairment of goodwill in subsidiaries, associates and joint arrangements (note 4) | 3,525 | – | –
Staff costs (note 23) | 5,267 | 5,295 | 5,519
Amounts related to inventory included in cost of sales | 5,886 | 6,045 | 6,464
Operating lease rentals payable | 3,826 | 3,788 | 3,976
Loss on disposal of property, plant and equipment and intangible assets | 33 | 36 | 22
Own costs capitalised attributable to the construction or acquisition of property, plant and equipment | (844) | (829) | (800)
Net gain on formation of VodafoneZiggo (note 26)2 | – | – | (1,275)


Question: Which financial years' information does this table show?
Answer: 2017, 2018, 2019
5. Goodwill and Purchased Intangible Assets
(b) Purchased Intangible Assets
The following tables present details of our purchased intangible assets (in millions):
Purchased intangible assets include intangible assets acquired through acquisitions as well as through direct purchases or licenses.
Impairment charges related to purchased intangible assets were approximately $47 million for fiscal 2017. Impairment charges were as a result of declines in estimated fair value resulting from the reduction or elimination of expected future cash flows associated with certain of our technology and IPR&D intangible assets.
Table:
July 27, 2019 | Gross | Accumulated Amortization | Net
Purchased intangible assets with finite lives: |  |  | 
Technology  . | $3,270 | $(1,933) | $1,337
Customer relationships . | 840 | (331) | 509
Other | 41 | (22) | 19
Total purchased intangible assets with finite lives | 4,151 | (2,286) | 1,865
In-process research and development, with indefinite lives . | 336 | — | 336
Total . | $4,487 | $(2,286) | $2,201


Question: What was the amount of gross purchased technology?
Answer: 3,270
Relative importance of the spend on pay
The following table shows the Group’s actual spend on pay for all employees compared to distributions to shareholders. The average number of employees has also been included for context. Revenue and Operating profit have also been disclosed as these are two key measures of Group performance.
1 2018 comparatives have been restated to reflect the adoption of IFRS 9, IFRS 15 and IFRS 16, and to include share buybacks.
Table:
 | 2019 | Restated 2018 | 
 | £m | £m | % change
Employee costs (see note 7 to the consolidated financial statements) | 56.0 | 54.5 | 3%
Average number of employees (see note 6 to the consolidated financial statements) | 802 | 822 | 3%
Revenue (see Consolidated income statement) | 355.1 | 330.1 | 8%
Operating profit | 243.7 | 221.3 | 10%
Dividends paid and proposed and share buybacks (see notes 26 and 27 to the consolidated financial statements) | 156.4 | 152.8¹ | 2%


Question: What was the change in employee costs in 2019 from 2018?
Answer: 1.5
Calculation: 56.0-54.5
Other (Income) Expenses
nm - not meaningful
Interest income. Interest income decreased $64,000 during fiscal 2018 as compared to fiscal 2017.
Interest expense. Interest expense consists of costs associated with capital leases and loans on corporate-owned life insurance policies.
Other (income) expense, net. Other (income) expense, net consists mainly of the impact of foreign currency due to movement of European and Asian currencies against the US dollar.
Table:
 | Year ended March 31, |  | (Unfavorable) favorable | 
(Dollars in thousands) | 2018 | 2017 | $ | %
Other (income) expenses |  |  |  | 
Interest (income) | $(98) | $(162) | $(64) | (39.5)%
Interest expense | 10 | 15 | 5 | 33.3%
Other (income) expense, net | (391) | 224 | 615 | nm
Total other (income) expense, net | $(479) | $77 | $556 | nm


Question: What are the interest expense comprised of?
Answer: costs associated with capital leases and loans on corporate-owned life insurance policies.
For a particular tax-paying component of the Company and within a particular tax jurisdiction, all current deferred tax liabilities and assets are offset and presented as a single amount, similarly to non-current deferred tax liabilities and assets. The Company does not offset deferred tax liabilities and assets attributable to different tax-paying components or to different tax jurisdictions.
The net deferred tax assets are recorded in legal entities which have been historically profitable and are expected to be profitable in the next coming years.
Table:
 | December 31, 2019 | December 31, 2018
Tax loss carryforwards and investment credits | 612 | 603
Less unrecognized tax benefit | (21) | (20)
Tax loss carry forwards net of unrecognized tax benefit | 591 | 583
Inventory valuation | 28 | 28
Impairment and restructuring charges | 6 | 14
Fixed asset depreciation in arrears | 39 | 35
Increased depreciation incentives | 213 | 211
Capitalized development costs | 118 | 108
Receivables for government funding | 14 | 11
Tax credits granted on past capital investments | 1,151 | 1,155
Pension service costs | 81 | 65
Stock awards | 6 | 7
Operating lease liabilities | 40 | —
Commercial accruals | 15 | 12
Other temporary differences | 22 | 26
Total deferred tax assets | 2,324 | 2,255
Valuation allowances | (1,534) | (1,548)
Deferred tax assets, net | 790 | 707
Accelerated fixed asset depreciation | (20) | (16)
Acquired intangible assets | (16) | (13)
Advances of government funding | (31) | (12)
Operating lease right-of-use assets | (40) | —
Other temporary differences | (7) | (7)
Deferred tax liabilities | (114) | (48)
Net deferred income tax asset | 676 | 659


Question: What is the increase/ (decrease) in Net deferred income tax asset from December 31, 2018 to 2019?
Answer: 17
Calculation: 676-659
equity compensation plan information the following table presents the equity securities available for issuance under our equity compensation plans as of december 31 , 2018 . equity compensation plan information plan category number of securities to be issued upon exercise of outstanding options , warrants and rights ( 1 ) weighted-average exercise price of outstanding options , warrants and rights number of securities remaining available for future issuance under equity compensation plans ( excluding securities reflected in column ( a ) ) ( a ) ( b ) ( c ) equity compensation plans approved by security holders 399165 $ 0.00 3995600 equity compensation plans not approved by security holders ( 2 ) 2014 2014 2014 .

Table:
plan category | number of securities to be issued upon exercise of outstanding options warrants and rights ( 1 ) ( a ) ( b ) | weighted-average exercise price of outstanding optionswarrants and rights | number of securities remaining available for future issuance under equity compensation plans ( excluding securitiesreflected in column ( a ) ) ( c )
equity compensation plans approved by security holders | 399165 | $ 0.00 | 3995600
equity compensation plans not approved by security holders ( 2 ) | 2014 | 2014 | 2014
total | 399165 | $ 0.00 | 3995600
( 1 ) includes grants made under the huntington ingalls industries , inc .
2012 long-term incentive stock plan ( the "2012 plan" ) , which was approved by our stockholders on may 2 , 2012 , and the huntington ingalls industries , inc .
2011 long-term incentive stock plan ( the "2011 plan" ) , which was approved by the sole stockholder of hii prior to its spin-off from northrop grumman corporation .
of these shares , 27123 were stock rights granted under the 2011 plan .
in addition , this number includes 31697 stock rights , 5051 restricted stock rights , and 335293 restricted performance stock rights granted under the 2012 plan , assuming target performance achievement .
( 2 ) there are no awards made under plans not approved by security holders .
item 13 .
certain relationships and related transactions , and director independence information as to certain relationships and related transactions and director independence will be incorporated herein by reference to the proxy statement for our 2019 annual meeting of stockholders , to be filed within 120 days after the end of the company 2019s fiscal year .
item 14 .
principal accountant fees and services information as to principal accountant fees and services will be incorporated herein by reference to the proxy statement for our 2019 annual meeting of stockholders , to be filed within 120 days after the end of the company 2019s fiscal year. .

Question: what portion of the equity compensation plan approved by security holders remains available for future issuance?
Answer: 90.9%
Calculation: add(399165, 3995600), divide(3995600, #0)
NOTE L – INCOME TAXES
On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”). The Tax Act makes broad and complex changes to the U.S. tax code, including, but not limited to, the following that impact the Company: (1) reducing the U.S. federal corporate income tax rate from 35 percent to 21 percent; (2) eliminating the corporate alternative minimum tax; (3) creating a new limitation on deductible interest expense; (4) limiting the deductibility of certain executive compensation; and (5) limiting certain other deductions.
The Company follows ASC 740-10 “Income Taxes” which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between financial statements and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.
A reconciliation of tax expense computed at the statutory federal tax rate on loss from operations before income taxes to the actual income tax (benefit) /expense is as follows:
Table:
 | 2019 | 2018
Tax benefit computed at the statutory rate | $(427,244) | $(631,497)
State taxes | 6,525 | 6,874
Book expenses not deductible for tax purposes | 2,980 | 2,882
Rate Change | 45,656 | –
Other | 2,517 | (27,286)
 | (369,566) | (649,027)
Change in valuation allowance for deferred tax assets | 269,203 | 658,650
Income tax (benefit) expense | $(100,363) | $9,623


Question: What is the percentage change in Book expenses not deductible for tax purposes from 2018 to 2019?
Answer: 3.4
Calculation: (2,980-2,882)/2,882
Liquidity and Capital Resources
As of December 31, 2019, we had total current assets of approximately $27.1 million, compared with current liabilities of approximately $6.1 million, resulting in working capital of approximately $21.0 million and a current ratio of approximately 4.4 to 1. This compares with the working capital balance of approximately $11.5 million and the current ratio of 3.7 to 1 at December 31, 2018. This increase in working capital, as discussed in more detail below, is primarily the result of the capital we raised in 2019.
Following is a table with summary data from the consolidated statement of cash flows for the years ended December 31, 2019 and 2018, as presented.
Our operating activities used approximately $1.7 million in the year ended December 31, 2019, as compared with approximately $0.8 million provided by operating activities in the year ended December 31, 2018. The cash provided in 2018 was the result of our net income and non-cash expenses, partially offset by the increased working capital required to support higher revenues. The cash used in operations in 2019 was the result of increased levels of working capital required to support higher revenue levels, expenditures related to growth, and costs associated with our acquisition in 2019.
We used approximately $5.7 million in investing activities in the year ended December 31, 2018, as compared with approximately $10.6 million used in investing activities in the year ended December 31, 2019. The majority of the investing activities in 2018 related to our acquisition of CareSpeak communications in October 2018. The majority of investing in activities in 2019 related to our acquisitions of RMDY Health, Inc. in 2019, as well as a software purchase in 2019.
Financing activities provided $8.7 million in the year ended December 31, 2018, as compared with $22.2 million in the year ended December 31, 2019. The cash provided in 2018 was primarily the result of the equity raised in connection with our uplisting to Nasdaq, as well as from the proceeds of option exercises. The cash used in 2019 was the result of our underwritten offering in 2019, as well as from the proceeds of option exercises.
With our cash on hand, we have sufficient cash to operate our business for more than the next 12 months and we do not anticipate the need to raise additional equity for operating purposes.
Table:
 | 2019 | 2018
Net cash provided by (used in) operating activities | $(1,660,796) | $792,555
Net cash used in investing activities | (10,582,086) | (5,686,833)
Net cash provided by financing activities | 22,181,528 | 8,685,739
Net increase in cash and cash equivalents | $9,938,646 | $3,791,461


Question: What is the average net cash provided by financing activities from 2018 to 2019?
Answer: 15433633.5
Calculation: (22,181,528+8,685,739)/2
ADJUSTED NET DEBT AND DEBT LEVERAGE RATIO
We use adjusted net debt and debt leverage ratio to conduct valuation-related analysis and make capital structure-related decisions. Adjusted net debt includes long-term debt, net debt derivative assets or liabilities, short-term borrowings, and cash and cash equivalents.
1 Includes current and long-term portion of long-term debt before deferred transaction costs and discounts. See “Reconciliation of adjusted net debt” in “Non-GAAP Measures and Related Performance Measures” for the calculation of this amount. 2 For purposes of calculating adjusted net debt and debt leverage ratio, we believe including debt derivatives valued without adjustment for credit risk is commonly used to evaluate debt leverage and for market valuation and transactional purposes.
3 See “Accounting Policies” for more information. 4 Adjusted net debt and adjusted EBITDA are non-GAAP measures and should not be considered substitutes or alternatives for GAAP measures. These are not defined terms under IFRS and do not have standard meanings, so may not be a reliable way to compare us to other companies. See “Non-GAAP Measures and Related Performance Measures” for information about these measures, including how we calculate themand the debt leverage ratio inwhich they are used.
As a result of our adoption of IFRS 16 effective January 1, 2019, we
have modified our definition of adjusted net debt such that it now includes the total of “current portion of lease liabilities” and “lease liabilities”. We believe adding total lease liabilities to adjusted net debt is appropriate as they reflect payments to which we are contractually committed and the related payments have been removed from our calculation of adjusted EBITDA due to the accounting change.
In addition, as at December 31, 2019, we held $1,831 million of
marketable securities in publicly traded companies (2018 – $1,051 million). Our adjusted net debt increased by $3,379 million from December 31, 2018 as a result of: • the inclusion of lease liabilities in the calculation, which had a balance of $1,725 million at year-end, as discussed above; and • a net increase in our outstanding long-term debt, in part due to the 600 MHz spectrum licences we acquired for $1,731 million this year; partially offset by • an increase in our net cash position.
See “Overview of Financial Position” for more information.
Table:
 | As at December 31 | As at January 1 | As at December 31
(In millions of dollars, except ratios) | 2019 | 2019 | 2018
Long-term debt 1 | 16,130 | 14,404 | 14,404
Net debt derivative assets valued without any adjustment for credit risk 2 | (1,414) | (1,448) | (1,448)
Short-term borrowings | 2,238 | 2,255 | 2,255
Lease liabilities 3 | 1,725 | 1,545 | –
Cash and cash equivalents | (494) | (405) | (405)
Adjusted net debt 4 | 18,185 | 16,351 | 14,806
Divided by: trailing 12-month adjusted EBITDA 4 | 6,212 | 6,157 | 5,983
Debt leverage ratio 4 | 2.9 | 2.7 | 2.5


Question: What is the increase/ (decrease) in Cash and cash equivalents from December 31, 2018 to December 31, 2019?
Answer: 89
Calculation: 494-405
Net Loss per Share
The Company applies the two-class method to calculate its basic and diluted net loss per share as both classes of its voting shares are participating securities with equal participation rights and are entitled to receive dividends on a share for share basis.
The following table summarizes the reconciliation of the basic weighted average number of shares outstanding and the diluted weighted average number of shares outstanding:
In the years ended December 31, 2019 and 2018, the Company was in a loss position and therefore diluted loss per share is equal to basic loss per share.
Table:
 | Years ended | 
 | December 31, 2019 | December 31, 2018
Basic and diluted weighted average number of shares outstanding | 113,026,424 | 105,671,839
The following items have been excluded from the diluted weighted average number of shares outstanding because they are anti-dilutive: |  | 
Stock options | 3,812,242 | 5,476,790
Restricted share units | 1,939,918 | 2,473,665
Deferred share units | 673 | 347
 | 5,752,833 | 7,950,802


Question: What financial information does the table show?
Answer: reconciliation of the basic weighted average number of shares outstanding and the diluted weighted average number of shares outstanding